Form 4 for IMCR Immunocore Holdings plc
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0001779466-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-19 | 2026-02-17 | IMCR | GOLL JOHN | SVP, CAO, Fin | M - OptEx | $0.00 | +1,351 | 1,351 | New | $0 |
| D | 2026-02-19 | 2026-02-18 | IMCR | GOLL JOHN | SVP, CAO, Fin | S - Sale+OE | $32.35 | -698 | 653 | -52% | -$22.6K |
| DM | 2026-02-19 | 2026-02-17 | IMCR | GOLL JOHN | SVP, CAO, Fin | A - Grant | $0.00 | +28.7K | 7,411 | New | $0 |
| D | 2026-02-19 | 2026-02-17 | IMCR | GOLL JOHN | SVP, CAO, Fin | M - OptEx | $0.00 | -1,351 | 4,054 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-17 | M | A | 1,351 | $0.00 | 1,351 | D | — | — | (F1) Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
| 2 | Common | Ordinary Shares | 2026-02-18 | S | D | 698 | $32.35 | 653 | D | — | — | (F1) Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. (F2) The shares were sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted share units ("RSUs") . (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.18 to $32.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Employee Share Option (Right to Buy) | 2026-02-17 | A | A | 21,252 | $0.00 | 21,252 | D | $32.38 · — to 2036-02-16 | 21,252 Ordinary Shares | (F7) 25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. |
| 4 | Derivative | Restricted Share Units | 2026-02-17 | A | A | 7,411 | $0.00 | 7,411 | D | — · — to — | 7,411 Ordinary Shares | (F4) Each RSU represents a contingent right to receive one Ordinary Share. (F6) The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date. |
| 5 | Derivative | Restricted Share Units | 2026-02-17 | M | D | 1,351 | $0.00 | 4,054 | D | — · — to — | 1,351 Ordinary Shares | (F4) Each RSU represents a contingent right to receive one Ordinary Share. (F5) On February 17, 2025, the Reporting Person was granted 5,405 RSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date. |